Pharma Insider Sells 4,772 Shares as 2025 Revenue Hits $883M
A high-stakes earnings year and a single insider trade create a nuanced picture for ANI Pharmaceuticals. This guide b...
Timing bond vs index fund choices in retirement affects risk and growth. Learn when to shift allocations for income.
25,546 articlesA high-stakes earnings year and a single insider trade create a nuanced picture for ANI Pharmaceuticals. This guide b...
Sportradar is at a pivotal moment as 2026 earnings unfold. This guide breaks down the numbers, the drivers behind gro...
An in-depth, grounded analysis of MDU Resources' Q1 2026 earnings call. Learn what to watch, how to model the numbers...
Piper Sandler lifts Cloudflare’s target to $250 despite a double-digit after-hours fall, arguing the core growth stor...
A lesser-known chip stock is catching the AI wave’s spotlight. This article breaks down why it’s rallying, what fuels...
Zebra Technologies stock jumped sharply this morning after a solid Q1 2026 report. This article breaks down the numbe...
A surprisingly strong first quarter has some investors asking if Stellantis can shake off years of underperformance. ...
BitMine slashed its weekly Ethereum purchases by 74% to 26,659 ETH, just as it edges toward a 5% stake of circulating...
AI stocks have dominated headlines, but long-term winners often come from durable franchises. This article explains w...
Palantir sits at the intersection of data software, government work, and commercial growth. Is it a palantir: risky i...
When Warren Buffett's successor Greg Abel took the helm, Berkshire Hathaway signaled a new phase. This article breaks...
This article breaks down what the stock market today is telling investors about NIO and the EV sector. Learn how reve...